XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,338 $ 1,566
Accounts receivable, net of allowance of $587 and $1,674, respectively 124,069 137,544
Inventory 81,761 84,622
Other current assets 5,989 8,228
Total current assets 213,157 231,960
Property, plant and equipment, net 2,301,982 2,199,253
Operating lease right-of-use assets 14,097 16,706
Intangible assets, net 30,182 37,077
Contract costs, net 37,739 34,736
Deferred tax assets 3,192 33,353
Other assets 47,733 37,079
Non-current assets of discontinued operations 7,868 8,586
Total assets 2,655,950 2,598,750
Current liabilities:    
Accounts payable, trade 61,026 64,324
Accrued liabilities 85,381 76,915
Deferred revenue 5,736 7,332
Total current liabilities 152,143 148,571
Long-term debt 1,584,869 1,548,334
Operating lease liabilities 12,271 14,861
Deferred tax liabilities 4,921 854
Other liabilities 22,857 17,569
Non-current liabilities of discontinued operations 7,868 7,868
Total liabilities 1,784,929 1,738,057
Commitments and contingencies (Note 16)
Equity:    
Preferred stock: $0.01 par value per share, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value per share, 250,000,000 shares authorized, 164,984,401 and 163,439,013 shares issued, respectively 1,650 1,634
Additional paid-in capital 3,470,576 3,456,777
Accumulated deficit (2,499,931) (2,509,133)
Treasury stock: 9,020,454 and 7,810,548 common shares, at cost, respectively (101,274) (88,585)
Total equity 871,021 860,693
Total liabilities and equity $ 2,655,950 $ 2,598,750